GNE-617
GNE-617 is a specific NAMPT inhibitor that inhibits the biochemical activity of NAMPT with an IC50 of 5 nM and exhibits efficacy in xenograft models of cancer.
Product Specifications
CAS Number
1362154-70-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
NAMPT
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/GNE-617.html
Purity
99.58
Solubility
DMSO : 16.67 mg/mL (ultrasonic)
Smiles
O=C(NCC1=CC=C(S(C2=CC(F)=CC(F)=C2)(=O)=O)C=C1)C3=CN4C(C=C3)=NC=C4
Molecular Formula
C21H15F2N3O3S
Molecular Weight
427.42
Precautions
H302, H315, H319, H335
References & Citations
[1]Shames DS, et al. Loss of NAPRT1 Expression by Tumor-specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. Clin Cancer Res. 2013 Dec 15;19 (24) :6912-23.|[2]Zabka TS, et al. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase. Toxicol Sci. 2015 Mar;144 (1) :163-72.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403102-500 1x 500 µL
Uroplakin 1B (Urothelial Differentiation Marker) (UPK1B/3102), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![PE Anti-Human CD47 Antibody[CC2C6D4]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d3881/imageurl/e-ab-f1060d.webp)